Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Sodium Iodide → Aripiprazole
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Sodium Iodide | HCID 5238 | — |
| 반응물 | Acetonitrile | HCID 6342 | — |
| 반응물 | 1-(2,3-Dichlorophenyl)piperazine | HCID 851833 | — |
| 반응물 | 7-(4-bromobutoxy)-3,4-dihydro-2(1H)-quinolinone | HCID 10542064 | — |
| 용매 | Chloroform | HCID 6212 | — |
| 용매 | Triethylamine | HCID 8471 | — |
| 생성물 | Aripiprazole | HCID 60795 | 80.8% |
반응 단계
A suspension of 47 g of 7-(4-bromobutoxy)-3,4-dihydrocarbostyril, 35 g of sodium iodide with 600 ml of acetonitrile was refluxed for 30 minutes. To this suspension was added 40 g of 1-(2,3-dichlorophenyl)piperazine and 33 ml of triethylamine and the whole mixture was further refluxed for 3 hours. After the solvent was removed by evaporation, the residue thus obtained was dissolved in chloroform, washed with water then dried with anhydrous magnesium sulfate. The solvent was removed by evaporation, and the residue thus obtained was recrystallized from ethanol twice, to yield 57.1 g of 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy}-3,4-dihydrocarbostyril.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08642760B2 |
| 출처 데이터셋 | uspto-grants-2014_02 |
| ORD ID | ord-a18fbd88147b417a889e11d3c18f357c |
| 출처 메모 | uspto-grants-2014_02 |